Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sechi, G. P.
Right arrow Articles by Rosati, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sechi, G. P.
Right arrow Articles by Rosati, G.
NEUROLOGY 1989;39:1113
© 1989 American Academy of Neurology

Treatment of cerebellar tremors with carbamazepine

A controlled trial with long-term follow-up

G. P. Sechi, MD, M. Zuddas, MD, M. Piredda, MD, V. Agnetti, MD, G. Sau, MD, M. L. Piras, MD, S. Tanca, MD and G. Rosati, MD

Department of Neurology, University of Sassari, Saasari, Italy.

We studied the effects of carbamazepine (CBZ) (400 and 600 mg per day) in 10 patients with cerebellar tremors in a single-blind manner. All patients improved on a clinical rating scale and by accelerometric recording; there was no improvement with placebo. Our data suggest that CBZ may be a valuable drug in cerebellar tremors.

Address correspondence and reprint requests to Dr. Sechi, Clinica Neurologica, Viale San Pietro, n.10, 07100 Sassari, Italy.

Received May 24, 1988. Accepted for publication in final form February 10, 1989.




This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
M. U. Farooq, A. Bhatt, A. Majid, R. Gupta, A. Khasnis, and M. Y. Kassab
Levetiracetam for managing neurologic and psychiatric disorders
Am. J. Health Syst. Pharm., March 15, 2009; 66(6): 541 - 561.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
P Feys, MB D'hooghe, G Nagels, and W. Helsen
The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis
Multiple Sclerosis, March 1, 2009; 15(3): 371 - 378.
[Abstract] [PDF]

Home page
 BrainHome page
S. H. Alusi, J. Worthington, S. Glickman, and P. G. Bain
A study of tremor in multiple sclerosis
Brain, April 1, 2001; 124(4): 720 - 730.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S H Alusi, J Worthington, S Glickman, L J Findley, and P G Bain
Evaluation of three different ways of assessing tremor in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, June 1, 2000; 68(6): 756 - 760.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S H ALUSI, S GLICKMAN, T Z AZIZ, and P G BAIN
Tremor in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, February 1, 1999; 66(2): 131 - 134.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.